Mylan gets FDA nod for generic cholesterol drug

05/19/2013 | RTT News

The FDA has granted Mylan Pharmaceuticals approval for its fenofibrate tablets in 48 mg and 145 mg strengths to reduce levels of low-density lipoprotein cholesterol, total cholesterol, triglycerides and apolipoprotein B, and boost high-density lipoprotein cholesterol. The drug is a generic version of Abbvie's Tricor.

View Full Article in:

RTT News

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Clinical Trials Agreements Specialist (209955)
The Henry M. Jackson Foundation for the Advancement of Military Medicine Inc.
Rockville, MD
SAFETY, HEALTH, and ENVIRONMENTAL (SHE) REGIONAL SPECIALIST
Matheson Tri-Gas, Inc.
Newark, CA
Catheter Engineer
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
MANAGER MEDICAL GAS COMPLIANCE AND SAFETY
Matheson Tri-Gas, Inc.
Houston, TX
Neurovascular Intervention Product Sales Rep, North East
ASAHI INTECC
Multiple Locations, SL_Multiple Locations